Medicines360
Medicines360's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $1,103,526 for Andrea Olariu, Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $1,132,563. It is higher than the D + F figure for 41 of 41 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue (approximately 100%; median $334,305). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Medicines360, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Clayton Foundation For Research | TX | $14,857,333 | $362,366 |
| Dolphins Cycling Challenge Inc | FL | $14,629,930 | $334,305 |
| The Zachary & Elizabeth M Fisher Center | NY | $14,515,618 | $393,286 |
| The Association For Frontotemporal | PA | $14,420,554 | $396,993 |
| Metis Foundation | TX | $14,394,121 | $503,928 |
| Asn Foundation For Kidney Research | DC | $14,217,105 | $66,131 |
| Novus Health Inc | MO | $15,301,646 | $203,108 |
| Steadman Philippon Research Institute | CO | $14,151,760 | $566,895 |
View the organization record and available filings on ProPublica